Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Beijing Northland Biotech Co. Ltd.
DescriptionRecombinant human interleukin-11
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationThrombocytopenia
Indication DetailsTreat chemotherpay induced thrombocytopenia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today